HYPERION DEFI, INC. Deferred Costs, Current
HYPERION DEFI, INC. (HYPD) had Deferred Costs, Current of $800.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredCostsCurrent · last filed 2022-03-30
- 2021-03-31: Deferred Costs, Current $800.00K.
- 2020-12-31: Deferred Costs, Current $1.60M.
- 2020-09-30: Deferred Costs, Current $1.60M.
| Period end | Deferred Costs, Current |
|---|---|
| 2021-03-31 | $800.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.60M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.60M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |